Home › Meningioma › Connecticut
Meningioma clinical trials in Connecticut
3 studies for Meningioma are looking for participants at sites in Connecticut.
Cities in Connecticut
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
- Yale University, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06955169Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Yale University, New Haven
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT02523014A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
- Yale-New Haven Hospital - Yale Cancer Center, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07533942From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.